UMass Chan Medical School

Phase II and III clinical trials establish standards of care in radiation oncology; however, achieving equivalent clinical outcomes in routine practice depends on the reproducible implementation of trial protocols. We systematically evaluated whether publishe...

The coming decade will reshape the practice of medical physics. Economic pressures, workforce shortages, and emerging technologies—particularly artificial intelligence (AI)—will challenge the traditional boundaries of our profession. To sustain excellence in...

As artificial intelligence becomes increasingly integral to clinical oncology and clinical trials, medical physicists are uniquely positioned to lead the development of the robust system architectures required to integrate AI safely and effectively. This sess...